You are here

EA-1929: Final Environmental Assessment

NorthStar Medical Technologies LLC, Commercial Domestic Production of the Medical Isotope Molybdenum-99

This EA evaluates the potential environmental impacts of a proposal to use federal funds to support and accelerate Northstar Medical Radioisotopes' project to develop domestic, commercial production capability for the medical isotope Molybdenum-99 without the use of highly enriched uranium.